期刊文献+

CT引导下组织间置入^(125)I粒子治疗肺癌的临床应用 被引量:58

The clinic application of CT-guided interstitial ^(125)I seeds implantation in curing lung cancer
原文传递
导出
摘要 目的 介绍CT引导下组织间置入125I粒子治疗肺癌的技术方法并评价其临床价值。方法 31例肺癌患者均在CT引导下进行肿瘤内125I粒子置入术。首先根据肿瘤的大小利用放射性粒子治疗计划系统计算出治疗肿瘤所需要125I粒子的最佳数量,然后经CT引导下经皮穿刺将125I粒子均匀置入到肿瘤内进行组织间放疗,术后1、2、6个月内分别进行CT检查对患者随访,根据肿瘤大小变化将疗效分为4级:Ⅰ级:明显缓解(肿瘤缩小50%以上);Ⅱ级:缓解(肿瘤缩小, 25% ~50% );Ⅲ级:轻度缓解(肿瘤缩小1% ~25% );Ⅳ级:无效(肿瘤无变化或增大,临床症状亦无缓解)。结果1个月:Ⅰ级9例,Ⅱ级6例,Ⅲ级13例,Ⅳ级3例(包括1例失访者), 1个月有效率为90. 32%; 2个月:Ⅰ级17例,Ⅱ级8例,Ⅲ级3例,Ⅳ级3例(包括2例失访者), 2个月有效率为90 .32%; 6个月:Ⅰ级23例,Ⅱ级3例,Ⅲ级2例,Ⅳ级3例(包括2例失访者), 6个月有效率为90. 32%。结论 CT导向下组织间置入125I粒子是1种治疗肺癌安全、可靠、疗效显著的治疗方法。 Objective To introduce the procedures and evaluate the clinic value of CT-guided interstitial 125I seeds implantation in treating lung cancer. Methods Thirty-one cases patients with lung cancer underwent CT-guided interstitial 125I seeds implantation. All patients were scanned on multi-spiral CT (Philips, MX 8000) with optical navigating system (pinpoint), and treatment plan system, needle, and 125I seeds (Chinese Academy of Science) were used. First of all, according to the size of tumor, TPS calculated the optimal quantity of seeds. Then, under the guidance of CT, 125I seeds were percutaneously implanted into the tumors for interstitial radiotherapy. CT follow-up examinations were performed 1, 2, and 6 months after the therapy, respectively. According to the size of tumor, curative effects were graded as 4 grades: grade Ⅰ: obvious relief (OR) (the size of tumor reduced up to 50%), grade Ⅱ: relief (PR) (the size of tumor reduced by 25%-50%), grade Ⅲ: slight relief (SD) (the size of tumor reduced by 1%-25%), and grade Ⅳ: no effect (PD) (the size of tumor did not reduce or increase, and clinic symptoms showed no relief). Results At 1 month, 9 cases were classified as grade Ⅰ, 6 as grade Ⅱ, 13 as grade Ⅲ, and 3 as grade Ⅳ, respectively. At 2 months, 17 cases were grade Ⅰ, 8 grade Ⅱ, 3 grade Ⅲ, and 3 grade Ⅳ, respectively. At 6 months, 23 cases were grade Ⅰ, 3 grade Ⅱ, 2 grade Ⅲ, and 3 grade Ⅳ, respectively. Conclusion CT-guided interstitial 125I seeds implanted was a safe, reliable, and effective curative method for lung cancer.
出处 《中华放射学杂志》 CAS CSCD 北大核心 2005年第5期490-492,共3页 Chinese Journal of Radiology
  • 相关文献

参考文献7

  • 1秦明秀 刁国平 等.临床介入核医学[M].天津:天津科学技术出版社,1996.209-241.
  • 2谷铣之.肿瘤放射治疗学[M].-,1991.504-505,517-518.
  • 3黄振国,张雪哲,王武,洛小林,王继英.CT导引下^(125)I粒子植入在治疗恶性肿瘤中的应用[J].中华放射学杂志,2004,38(9):921-925. 被引量:135
  • 4Marchese MJ, Hall EJ, Hilaris BS, et al. Encapsulated iodine-125 in radiation oncology. Am J Clin Oncol, 1984, 7:607-611.
  • 5Goffinet D, Ling CC, Mariscal M, et al. Using of 125I in breast implants. Endocur Hypertherm Oncol, 1987, 3:121-125.
  • 6De Silva VF, Gutin PH, Deen DF, et al. Relative biological effectiveness of 125I sources in a murine brachytherapy model. Int J Radia Oncol Biol Phys, 1984, 10:2109-2111.
  • 7胡效坤,王明友,杨志国,邱春东,吕东方,李晓东,左太阳.CT导引下经皮穿刺组织间植入^(125)I放射微粒子治疗中心型肺癌的应用研究[J].中华放射学杂志,2004,38(9):910-915. 被引量:117

二级参考文献16

  • 1Cady B,Jenkins RL,Steele GD Jr,et al.Surgical margin in hepatic resection for colorectal metastasis:a critical and improvable determinant of outcome.Ann Surg,1998,227:566-571.
  • 2Rieber A,Brambs HJ,Kauffmann G,et al.Combined intra-arterial chemotherapy and radiotherapy in inoperable non-small cell bronchial carcinoma.Strhlenter Onkol(German),1991,167:14-18.
  • 3Miyaji N,Oyama T,Uchiyama N,et al.Results of radiotherapy combined with BAI(bronchial artery infusion) for non-small cell lung cancer--analysis of 104 cases. Nippon Igaku Hoshasen Gakkai Zsshi(Japanese),1991,51:270-281.
  • 4Murakami M,Kuroda Y,Sano A,et al.Therapeutic results of non-small cell lunch cancer in stager Ⅲ:combined synchronous irradiation with bronchial artery infusion of CDDP. Nippon Igaku Hoshasen Gakkai Zasshi(Japanese),1995,55:44-49.
  • 5Zelefsky MJ, Hollister T, Raben A, et al. Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer. Int J Radiat Oncol Biol Phys,2000,47:1261-1266.
  • 6Willins J, Wallner K. CT-based dosimetry for transperineal I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys,1997,39:347-353.
  • 7Molloy JA, Williams MB. Treatment planning considerations and quality assurance for CT-guided transischiorectal implantation of the prostate. Med Phys,1999,26:1943-1951.
  • 8Martinez-Monge R, Nag S, Nieroda CA, et al. Iodine-125 brachytherapy in the treatment of colorectal adenocarcinoma metastatic to the liver. Cancer,1999,85:1218-1225.
  • 9Vikram B, Mishra S.Permanent iodine-125 implants in postoperative radiotherapy for head and neck cancer with positive surgical margins. Head Neck,1994,16:155-157.
  • 10Kumar PP, Patil AA, Leibrock LG,et al. Continuous low dose rate brachytherapy with high activity iodine-125 seeds in the management of meningiomas. Int J Radiat Oncol Biol Phys,1993,25:325-328.

共引文献239

同被引文献401

引证文献58

二级引证文献351

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部